Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials

Clinical Toxicology

Volumn 47, Issue 6, 2009, Pages 566-572

  Björnstad, Kristian ^a   Hultén, Peter ^b   Beck, Olof ^a   Helander, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Swedish Poisons Information Center   (Sweden)

Author keywords

Hallucinogens; LCMS; Plant derived drugs; Poisoning; Psychoactive

Indexed keywords

ASARONE; ATROPINE; EPHEDRINE; HARMALINE; HARMINE; IBOGAINE; ILLICIT DRUG; LYSERGIC ACID; N,N DIMETHYLTRYPTAMINE; PSILOCIN; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; SCOPOLAMINE; PLANT EXTRACT;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL EXAMINATION; COMPARTMENT MODEL; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; INGESTION; INTERNET; INTOXICATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MUSHROOM; NONHUMAN; PLANT PRODUCT; SWEDEN; TANDEM MASS SPECTROMETRY; URINALYSIS; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; EMERGENCY HEALTH SERVICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; PLANT; URINE;

BASIDIOMYCOTA;

ADOLESCENT; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EMERGENCY SERVICE, HOSPITAL; FEMALE; HALLUCINOGENS; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; PLANTS, TOXIC; POISONING; PSYCHOTROPIC DRUGS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 67651162416     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650903037181     Document Type: Article

References (40)

1. Halpern JH, Sewell RA. Hallucinogenic botanicals of America: a growing need for focused drug education and research. Life Sci 2005; 78:519-526.
2. Rätsch C. The Encyclopedia of Psychoactive Plants. Rochester: Park Street Press; 2005.
3. Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther 2004; 102:131-138.
4. Richardson WH III, Slone CM, Michels JE. Herbal drugs of abuse: an emerging problem. Emerg Med Clin North Am 2007; 25:435-457; Abstract ix.
5. Gordon SM, Forman RF, Siatkowski C. Knowledge and use of the Internet as a source of controlled substances. J Subst Abuse Treat 2006; 30:271-274.
6. Montagne M. Drugs on the Internet. I: introduction and web sites on psychedelic drugs. Subst Use Misuse 2008; 43:17-25.
7. Wax PM. Just a click away: recreational drug Web sites on the Internet. Pediatrics 2002; 109:e96.
8. EMCDDA. European Legal Database on Drugs. http://eldd. emcdda.europa.eu/html.cfm/index5029EN.html. Accessed 28 April 2009.
9. Boyer EW, Shannon M, Hibberd PL. The Internet and psychoactive substance use among innovative drug users. Pediatrics 2005; 115:302-305.
10. Kresanek J, Plackova S, Caganova B, Klobusicka Z. Drug abuse in Slovak Republic. Przegl Lek 2005; 62:357-360.
11. Kontrimaviciute V, Mathieu O, Mathieu-Daude JC, Vainauskas P, Casper T, Baccino E, Bressolle FM. Distribution of ibogaine and noribogaine in a man following a poisoning involving root bark of the Tabernanthe iboga shrub. J Anal Toxicol 2006; 30:434-440.
12. Cheze M, Lenoan A, Deveaux M, Pepin G. Determination of ibogaine and noribogaine in biological fluids and hair by LC-MS/MS after Tabernanthe iboga abuse: iboga alkaloids distribution in a drowning death case. Forensic Sci Int 2008; 176:58-66.
13. Marneros A, Gutmann P, Uhlmann F. Self-amputation of penis and tongue after use of Angel's Trumpet. Eur Arch Psychiatry Clin Neurosci 2006; 256:458-459.
14. Borsutzky M, Passie T, Paetzold W, Emrich HM, Schneider U. [Hawaiian baby woodrose: (psycho-) pharmacological effects of the seeds of Argyreia nervosa. A case-orientated demonstration]. Nervenarzt 2002; 73:892-896.
15. Mahmoudian M, Jalipour H, Salehian P. Toxicity of Peganum harmala: review and a case report. Iran J Pharmcol Ther 2002; 1:1-4.
16. Balikova M. Collective poisoning with hallucinogenous herbal tea. Forensic Sci Int 2002; 128:50-52.
17. Borowiak KS, Ciechanowski K, Waloszczyk P. Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction. J Toxicol Clin Toxicol 1998; 36:47-49.
18. Satora L, Goszcz H, Ciszowski K. Poisonings resulting from the ingestion of magic mushrooms in Krakow. Przegl Lek 2005; 62:394-396.
19. Beyer J, Ehlers D, Maurer HH. Abuse of nutmeg (Myristica fragrans Houtt.): studies on the metabolism and the toxicologic detection of its ingredients elemicin, myristicin, and safrole in rat and human urine using gas chromatography/mass spectrometry. Ther Drug Monit 2006; 28:568-575.
20. Forrester MB. Jimsonweed (Datura stramonium) exposures in Texas, 1998-2004. J Toxicol Environ Health A 2006; 69:1757-1762.
21. Forrester MB. Nutmeg intoxication in Texas, 1998-2004. Hum Exp Toxicol 2005; 24:563-566.
22. Persson HE, Sjöberg GK, Haines JA, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998; 36:205-213.
23. Björnstad K, Beck O, Helander A. A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:1162-1168.
24. Adams RG, Verma P, Jackson AJ, Miller RL. Plasma pharmacokinetics of intravenously administered atropine in normal human subjects. J Clin Pharmacol 1982; 22:477-481.
25. Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC. Pharmacokinetics of Hoasca alkaloids in healthy humans. J Ethnopharmacol 1999; 65:243-256.
26. Csajka C, Haller CA, Benowitz NL, Verotta D. Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects. Br J Clin Pharmacol 2005; 59:335-345.
27. Haller CA, Jacob P 3rd, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002; 71:421-432.
28. Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 2005; 27:655-665.
29. Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther 2003; 306:73-83.
30. Heyerdahl F, Hovda KE, Bjornaas MA, Brors O, Ekeberg O, Jacobsen D. Clinical assessment compared to laboratory screening in acutely poisoned patients. Hum Exp Toxicol 2008; 27:73-79.
31. Lee MO, Vivier PM, Diercks DB. Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the Emergency Department with chest pain? J Emerg Med 2008, doi: 10.1016/j.jemermed.2008.05.024.
32. Salzman E, Rumack BH. Mushroom Poisoning: Diagnosis and Treatment. Cleveland: CRC Press; 1978.
33. Beck O, Helander A, Karlson-Stiber C, Stephansson N. Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions. J Anal Toxicol 1998; 22:45-49.
34. Peden NR, Bissett AF, Macaulay KE, Crooks J, Pelosi AJ. Clinical toxicology of "magic mushroom" ingestion. Postgrad Med J 1981; 57:543-545.
35. Al-Assmar SE. The seeds of the Hawaiian baby woodrose are a powerful hallucinogen. Arch Intern Med 1999; 159:2090.
36. Cohen S. Suicide following morning glory seed ingestion. Am J Psychiatry 1964; 120:1024-1025.
37. Frison G, Favretto D, Zancanaro F, Fazzin G, Ferrara SD. A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Sci Int 2008; 179:e37-e43.
38. Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: systematic review. Obes Rev 2005; 6:93-111.
39. Vargas CP, Wolf LR, Gamm SR, Koontz K. Getting to the root (Acorus calamus) of the problem. J Toxicol Clin Toxicol 1998; 36:259-260.
40. Hoffer A, Osmond H. The Hallucinogens. New York: Academic Press 1967.